Halozyme Therapeutics, Inc. (HALO)
66.98
-0.84
(-1.24%)
USD |
NASDAQ |
Apr 13, 16:00
66.93
-0.05
(-0.07%)
After-Hours: 20:00
Halozyme Therapeutics Cash from Investing (TTM) : -545.81M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Johnson & Johnson | -23.59B |
| Eli Lilly & Co. | -10.97B |
| Vertex Pharmaceuticals, Inc. | -945.40M |
| Glaukos Corp. | -77.61M |
| Agenus, Inc. | 1.194M |